Publications in VIVO

Co-author Network

Co-investigator Network

Mara McAdams DeMarco, PhD

Person

Positions

Associate Professor, New York University Grossman School of Medicine

Clinical Disciplines

Publications
Research
Other
View All

Selected Publications

article
1. A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis. Kidney360. 2026
2. Author Response to Computed Tomography Instrumentation and Myosteatosis Thresholds as Explanations for the Different Impact of Myosteatosis across Kidney Transplant Recipient Populations. Clinical Journal of the American Society of Nephrology. 2026
3. Response to Letter to the Editor by Kumar, et al.. Clinical Transplantation. 2026
4. Evaluating the representativeness and validity of Cosmos as a novel, large-scale, real-world data source for liver transplant research.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2025
5. Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 40:662-670. 2025
6. Cognitive dysfunction, psychiatric distress, and functional decline after liver transplantation.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 31:1020-1030. 2025
7. Aging and Infections in Solid Organ Transplantation: Unchartered Territory. Transplant Infectious Disease. 2025
8. Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis. Clinical Transplantation. 2025
9. Exercise Prehabilitation in Kidney Transplant Candidates: Insights From the FRAILMar Trial. American Journal of Kidney Diseases. 2025
10. Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients. American Journal of Transplantation. 2025
11. Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality. Clinical Transplantation. 2025
12. Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease. American Journal of Gastroenterology. 2025
13. Sexual bother and sexual activity before and after kidney transplantation. American Journal of Transplantation. 2025
14. Utilization and Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists in Posttransplant Diabetes Mellitus in Kidney Transplant Recipients. Clinical Transplantation. 2025
15. Weight Loss Intentionality and Frailty are Associated with Pre–Kidney Transplant Outcomes. Clinical Journal of the American Society of Nephrology. 2025
16. “You Gotta Keep Climbing That Mountain to Reach the Goal”: Perspectives of Transplant Waitlisted Dialysis Patients. A Qualitative Study. Kidney Medicine. 2025
17. Extreme Humid-Heat Exposure and Mortality Among Patients Receiving Dialysis.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 84:582-592.e1. 2024
18. Neighborhood Segregation and Access to Live Donor Kidney Transplantation.. JAMA internal medicine. 184:402-413. 2024
19. Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects. Journal of the American Society of Nephrology. 2024
20. COVID-19 and Access to Kidney Transplantation for Older Candidates in the United States: A National Registry Study. Kidney Medicine. 2024
21. ChatGPT Solving Complex Kidney Transplant Cases: A Comparative Study With Human Respondents. Clinical Transplantation. 2024
22. Obesogenic Medication Use in End‐Stage Kidney Disease and Association With Transplant Listing. Clinical Transplantation. 2024
23. Sleep Disorders and Dementia Risk in Older Patients with Kidney Failure. Clinical Journal of the American Society of Nephrology. 2024
24. Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records. Clinical Transplantation. 2024
25. The Impact of Kidney Transplantation on a Breadth of Cognitive Measures. American Journal of Kidney Diseases. 2024
26. Using Photovoice to Explore the Lived Environment and Experience of Older Adults with Frailty on their Kidney Transplant Journey. Kidney360. 2024
27. Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease. Circulation. 2023
28. Cognitive Dysfunction in Liver Disease and Its Implications for Transplant Candidates. Current Transplantation Reports. 2023
29. Delirium in Liver Transplantation. Current Transplantation Reports. 2023
30. Evolving Trends in Kidney Transplant Outcomes Among Older Adults: A Comparative Analysis Before and During the COVID-19 Pandemic. Transplantation Direct. 2023
31. Frailty Assessment as Part of Transplant Listing: Yes, No, or Maybe?. Clinical Kidney Journal. 2023
32. Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 2023
33. Sleep duration and cognitive function among older adults with chronic kidney disease – results from the National Health and Nutrition Examination Survey (2011-2014). Nephrology Dialysis Transplantation. 2023
34. Chronic kidney disease, physical activity and cognitive function in older adults—results from the National Health and Nutrition Examination Survey (2011–2014). Nephrology Dialysis Transplantation. 2022
35. Delirium, Changes in Cognitive Function, and Risk of Diagnosed Dementia After Kidney Transplantation. American Journal of Transplantation. 2022
36. Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist. Kidney International Reports. 2022
37. Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin. Journal of Clinical Epidemiology. 2022
38. Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms. Journal of Clinical Epidemiology. 2022
39. Hurricanes and Mortality among Patients Receiving Dialysis. Journal of the American Society of Nephrology. 2022
40. Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage. Surgery. 2022
41. Long-Term Trajectories of Frailty and Its Components After Kidney Transplantation. The Journals of Gerontology: Series A. 2022
42. Moving toward clinical implementation of the physical frailty phenotype in kidney transplantation. American Journal of Transplantation. 2022
43. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery. 2022
44. Revision of frailty assessment in kidney transplant recipients: Replacing unintentional weight loss with CT-assessed sarcopenia in the physical frailty phenotype. American Journal of Transplantation. 2022
45. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia. Nephrology Dialysis Transplantation. 2022
46. Sleep disorders and the development of Alzheimer's disease among U.S. Medicare beneficiaries. Journal of the American Geriatrics Society. 2022
47. Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care. Clinical Kidney Journal. 2022
48. Ambient air pollution and posttransplant outcomes among kidney transplant recipients. American Journal of Transplantation. 2021
49. Comparing outcomes of third and fourth kidney transplantation in older and younger patients. American Journal of Transplantation. 2021
50. Development and Validation of an Inflammatory-Frailty Index for Kidney Transplantation. The Journals of Gerontology: Series A. 2021
51. Frailty, Age, and Postdialysis Recovery Time in a Population New to Hemodialysis. Kidney360. 2021
52. High-dose opioid utilization and mortality among individuals initiating hemodialysis. BMC Nephrology. 2021
53. Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study. Clinical Transplantation. 2021
54. Pre-kidney transplant unintentional weight loss leads to worse post-kidney transplant outcomes. Nephrology Dialysis Transplantation. 2021
55. The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver International. 2021
56. Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation. Clinical Journal of the American Society of Nephrology. 2020
57. Benzodiazepines, Codispensed Opioids, and Mortality among Patients Initiating Long-Term In-Center Hemodialysis. Clinical Journal of the American Society of Nephrology. 2020
58. Differences Between Cystatin C– and Creatinine-Based Estimated GFR—Early Evidence of a Clinical Marker for Frailty. American Journal of Kidney Diseases. 2020
59. Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function. Journal of the American Society of Nephrology. 2020
60. Economic impacts of alternative kidney transplant immunosuppression: A national cohort study. Clinical Transplantation. 2020
61. Functional independence, access to kidney transplantation and waitlist mortality. Nephrology Dialysis Transplantation. 2020
62. Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data. Clinical Transplantation. 2020
63. Interventions Made to Preserve Cognitive Function Trial (IMPCT) study protocol: a multi-dialysis center 2x2 factorial randomized controlled trial of intradialytic cognitive and exercise training to preserve cognitive function. BMC Nephrology. 2020
64. Interventions to Preserve Cognitive Functioning among Older Kidney Transplant Recipients. Current Transplantation Reports. 2020
65. Outcome implications of benzodiazepine and opioid co‐prescription in kidney transplant recipients. Clinical Transplantation. 2020
66. Prevalence of frailty among kidney transplant candidates and recipients in the United States: Estimates from a National Registry and Multicenter Cohort Study. American Journal of Transplantation. 2020
67. The Long Road to Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 2020
68. A donor risk index for graft loss in pediatric living donor kidney transplantation. American Journal of Transplantation. 2019
69. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019
70. Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation. American Journal of Transplantation. 2019
71. Prehabilitation prior to kidney transplantation: Results from a pilot study. Clinical Transplantation. 2019
72. Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes. American Journal of Transplantation. 2019
73. Survival benefit of accepting livers from deceased donors over 70 years old. American Journal of Transplantation. 2019
74. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation. Nephrology. 2019
75. Dementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation. Clinical Journal of the American Society of Nephrology. 2018
76. Pre-Kidney Transplant Lower Extremity Impairment and Post-Kidney Transplant Mortality. American Journal of Transplantation. 2018
77. Pre-kidney transplant lower extremity impairment and transplant length of stay: a time-to-discharge analysis of a prospective cohort study. BMC Geriatrics. 2018
78. The Role of Bicarbonate in Cognition. Clinical Journal of the American Society of Nephrology. 2018
79. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care and Research. 2016
80. Changes in body mass index and obesity risk in married couples over 25 years. American Journal of Epidemiology. 2016
81. Dual-energy computed tomography has limited sensitivity for non-tophaceous gout: A comparison study with tophaceous gout. BMC Musculoskeletal Disorders. 2016
82. Early Hospital Readmission after Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors. American Journal of Transplantation. 2016
83. Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial. Arthritis and Rheumatology. 2016
84. Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Annals of Surgery. 2016
85. Gout in older adults: The atherosclerosis risk in communities study. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2016
86. Individual Frailty Components and Mortality In Kidney Transplant Recipients. Transplantation. 2016
87. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. American Journal of Transplantation. 2016
88. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Kidney Diseases. 2016
89. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study. Mayo Clinic Proceedings. 2016
90. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Thrombosis Research. 2016
91. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis. BMC Nephrology. 2016
92. Changes in frailty after kidney transplantation. Journal of the American Geriatrics Society. 2015
93. Frailty and cognitive function in incident hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2015
94. Frailty and mortality in kidney transplant recipients. American Journal of Transplantation. 2015
95. Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation. 2015
96. Perceived frailty and measured frailty among adults undergoing hemodialysis: A cross-sectional analysis. BMC Geriatrics. 2015
97. Perceptions about hemodialysis and transplantation among African American adults with end-stage renal disease: Inferences from focus groups. BMC Nephrology. 2015
98. Physical Function, Hyperuricemia, and Gout in Older Adults. Arthritis Care and Research. 2015
99. Plasma urate and risk of a hospital stay with AKI: The atherosclerosis risk in communities study. Clinical Journal of the American Society of Nephrology. 2015
100. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: The German Chronic Kidney Disease (GCKD) study. Nephrology Dialysis Transplantation. 2015
101. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome. Annals of the Rheumatic Diseases. 2015
102. Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. Journal of the American Geriatrics Society. 2014
103. Health-related and psychosocial concerns about transplantation among patients initiating dialysis. Clinical Journal of the American Society of Nephrology. 2014
104. Patient- And Provider-Reported Information about Transplantation and Subsequent Waitlisting. Journal of the American Society of Nephrology. 2014
105. Racial differences in gout incidence in a population-based cohort: Atherosclerosis risk in communities study. American Journal of Epidemiology. 2014
106. Sequelae of early hospital readmission after kidney transplantation. American Journal of Transplantation. 2014
107. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. American Journal of Epidemiology. 2014
108. The association of spousal smoking status with the ability to quit smoking: The atherosclerosis risk in communities study. American Journal of Epidemiology. 2014
109. Trends in kidney transplant outcomes in older adults. Journal of the American Geriatrics Society. 2014
110. A urate gene-by-diuretic interaction and gout risk in participants with hypertension: Results from the ARIC study. Annals of the Rheumatic Diseases. 2013
111. Frailty and early hospital readmission after kidney transplantation. American Journal of Transplantation. 2013
112. Frailty and falls among adult patients undergoing chronic hemodialysis: A prospective cohort study. BMC Nephrology. 2013
113. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. Journal of the American Geriatrics Society. 2013
114. Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study. BMC Musculoskeletal Disorders. 2013
115. Activity of daily living disability and dialysis mortality: Better prediction using metrics of aging. Journal of the American Geriatrics Society. 2012
116. Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study. Arthritis Research and Therapy. 2012
117. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study. Arthritis and Rheumatism. 2012
118. Early hospital readmission after kidney transplantation: Patient and center-level associations. American Journal of Transplantation. 2012
119. Hypertension and the Risk of Incident Gout in a Population-Based Study: The Atherosclerosis Risk in Communities Cohort. Journal of Clinical Hypertension. 2012
120. Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Medicine. 2012
121. Recipient age and time spent hospitalized in the year before and after kidney transplantation. Transplantation. 2012
122. Hypertension status, treatment, and control among spousal pairs in a middle-aged adult cohort. American Journal of Epidemiology. 2011
123. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care and Research. 2011
124. Reliability and sensitivity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community cohorts. Journal of Rheumatology. 2011
125. Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: The ARIC study. Preventive Medicine. 2010
126. Observation plans in longitudinal studies with time-varying treatments. Statistical Methods in Medical Research. 2009
127. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiology and Drug Safety. 2008
128. Estimating the extent of reporting to FDA: A case study of statin-associated rhabdomyolysis. Pharmacoepidemiology and Drug Safety. 2008
129. Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: Revisiting the Weber effect. Pharmacoepidemiology and Drug Safety. 2008
130. Comparison of self-reported and measured BMI as correlates of disease markers in U.S. adults. Obesity. 2007
131. The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs. Contraception. 2007
document
1. Empowering Older Adults Through Values-Informed Solutions for Technology Adoption (VISTA): A Feasibility and Acceptability Randomized Control Pilot Trial Protocol (Preprint) 2025
2. Development and Validation of an Abridged Physical Frailty Phenotype for Clinical Use: A Cohort Study Among Kidney Transplant Candidates 2023